Metraipolis › archive › dc_057d2bc1f51f

Avasimibe — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Avasimibe
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-10T12:34:09.669Z
SHA-256 of the archived text
f683645561651e1923e397f099f0d01060d5ad67aa9a5a67d093d9519caf80f5
Stable URL of this page
https://metraipolis.com/documento/dc_057d2bc1f51f

How to cite

Avasimibe — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Avasimibe (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_057d2bc1f51f (Metraipolis archive dc_057d2bc1f51f, sha256 f683645561651e1923e397f099f0d01060d5ad67aa9a5a67d093d9519caf80f5)
BibTeX
@misc{dc057d2bc1f51f,
  title = {Avasimibe — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Avasimibe},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_057d2bc1f51f; sha256 f683645561651e1923e397f099f0d01060d5ad67aa9a5a67d093d9519caf80f5},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Avasimibe. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Avasimibe (INN), codenamed CI 1011, is a drug that inhibits sterol O-acyltransferases (SOAT1 and SOAT2, also known as ACAT1 and ACAT2), enzymes involved in the metabolism and catabolism of cholesterol. It was discovered by Parke-Davis (later Pfizer) and developed as a possible lipid-lowering agent and treatment for atherosclerosis. The first description of avasimibe was published in 1996. Clinical trials began in 1997. However, development was halted in 2003 due to a high potential for interactions with other medicines, and a pivotal study found it had no favorable effect on atherosclerosis and actually increased LDL cholesterol levels significantly. SOAT/ACAT inhibition has since been discredited as a viable strategy for treating high cholesterol and atherosclerosis, but renewed interest in avasimibe has arisen due to its potential antitumor utility through other mechanisms. It has never been marketed or used outside clinical trials.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Avasimibe» — https://en.wikipedia.org/wiki/Avasimibe
Wikidata Q112114878 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q112114878
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Avasimibe?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1345337139, consultata il 2026-11-10T12:29:38.854Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: e65dffc3ebac45d0b909229384a10622f2b0dfb934bce88c5a1184f0e22a5f49